Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.56, Iss.8, 2011-08, pp. : 2372-2377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease

By Reinders Claudia Jonkers Daisy Jansson Emmelie Å. Stockbrügger Reinhold Stobberingh Ellen Hellström Per Lundberg Jon

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 10, 2007-01 ,pp. : 1151-1157

Informa Healthcare

Access to resources Recommend Favorite

The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

By Kolho Kaija-Leena Sipponen Taina

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 4, 2014-04 ,pp. : 434-441

Informa Healthcare

Access to resources Recommend Favorite

Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease

By Røseth A. G. Aadland E. Grzyb K.

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 10, 2004-10 ,pp. : 1017-1020

Informa Healthcare

Access to resources Recommend Favorite

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

By Kolho Kaija-Leena Raivio Taneli Lindahl Harry Savilahti Erkki

Scandinavian Journal of Gastroenterology, Vol. 41, Iss. 6, 2006-06 ,pp. : 720-725

Informa Healthcare

Access to resources Recommend Favorite

Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin

Digestive Diseases, Vol. 31, Iss. 3-4, 2013-11 ,pp. : 336-344

Karger

Access to resources Recommend Favorite